FindTrial
Sign In

Anticoagulant effects of different calcium supplementation pathways in calcium-free RCA-CRRT: a prospective randomized cross-over trial

Anticoagulant effects of different calcium supplementation pathways in calcium-free RCA-CRRT: a prospective randomized cross-over trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020046
Enrollment
Unknown
Registered
2018-12-12
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

continuous renal replacement therapy, CRRT

Interventions

Group A:End-subclavian vein of hemofiltration catheter-venae subclavia
Group B:venae subclavia - End-subclavian vein of hemofiltration catheter

Sponsors

Department of Nursing, The First Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Adult patients (age = 18 years of age) receiving RCA-CRRT with hemodialysis puncture in femoral vein.

Exclusion criteria

Exclusion criteria: Patients refused; patients with intravenous calcium or oral calcium before enrollment; patients with hypercalcemia (iCa2+>1.35mmol/L) before enrollment.

Design outcomes

Primary

MeasureTime frame
iCa2 + of outer circumference;iCa2+ after filter;hypocalcemia;—

Secondary

MeasureTime frame
Catheter dysfunction;—

Countries

China

Contacts

Public ContactZhang Zhigang

Department of Nursing, The First Hospital of Lanzhou University

zzg3444@163.com+86 13919093444

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026